Your browser doesn't support javascript.
loading
Targeting genome integrity dysfunctions impedes metastatic potency in non-small cell lung cancer circulating tumor cell-derived explants.
Tayoun, Tala; Faugeroux, Vincent; Oulhen, Marianne; Déas, Olivier; Michels, Judith; Brulle-Soumare, Laura; Cairo, Stefano; Scoazec, Jean-Yves; Marty, Virginie; Aberlenc, Agathe; Planchard, David; Remon, Jordi; Ponce, Santiago; Besse, Benjamin; Kannouche, Patricia L; Judde, Jean-Gabriel; Pawlikowska, Patrycja; Farace, Françoise.
Afiliação
  • Tayoun T; Gustave Roussy, Paris-Saclay University, "Circulating Tumor Cells" Translational Platform, CNRS UMS3655 - INSERM US23 AMMICA, Villejuif, France.
  • Faugeroux V; INSERM, U981 "Identification of Molecular Predictors and new Targets for Cancer Treatment", Villejuif, France.
  • Oulhen M; Gustave Roussy, Paris-Saclay University, "Circulating Tumor Cells" Translational Platform, CNRS UMS3655 - INSERM US23 AMMICA, Villejuif, France.
  • Déas O; INSERM, U981 "Identification of Molecular Predictors and new Targets for Cancer Treatment", Villejuif, France.
  • Michels J; Gustave Roussy, Paris-Saclay University, "Circulating Tumor Cells" Translational Platform, CNRS UMS3655 - INSERM US23 AMMICA, Villejuif, France.
  • Brulle-Soumare L; INSERM, U981 "Identification of Molecular Predictors and new Targets for Cancer Treatment", Villejuif, France.
  • Cairo S; XenTech, Evry, France.
  • Scoazec JY; Gustave Roussy, Paris-Saclay University, Department of Cancer Medicine, Villejuif, France.
  • Marty V; XenTech, Evry, France.
  • Aberlenc A; XenTech, Evry, France.
  • Planchard D; Gustave Roussy, Paris-Saclay University, "Histo-Cytopathology" Translational Platform, CNRS UMS3655 - INSERM US23 AMMICA, Villejuif, France.
  • Remon J; Gustave Roussy, Paris-Saclay University, "Histo-Cytopathology" Translational Platform, CNRS UMS3655 - INSERM US23 AMMICA, Villejuif, France.
  • Ponce S; Gustave Roussy, Paris-Saclay University, "Circulating Tumor Cells" Translational Platform, CNRS UMS3655 - INSERM US23 AMMICA, Villejuif, France.
  • Besse B; INSERM, U981 "Identification of Molecular Predictors and new Targets for Cancer Treatment", Villejuif, France.
  • Kannouche PL; Gustave Roussy, Paris-Saclay University, Department of Cancer Medicine, Villejuif, France.
  • Judde JG; Department of Medical Oncology, Clara Campal Comprehensive Oncology Center (HM-CIOCC), Hospital HM New Delphi, HM Hospitals, Barcelona, Spain.
  • Pawlikowska P; INSERM, U981 "Identification of Molecular Predictors and new Targets for Cancer Treatment", Villejuif, France.
  • Farace F; Gustave Roussy, Paris-Saclay University, Department of Cancer Medicine, Villejuif, France.
JCI Insight ; 7(11)2022 06 08.
Article em En | MEDLINE | ID: mdl-35511434
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Carcinoma de Pequenas Células do Pulmão / Neoplasias Pulmonares / Células Neoplásicas Circulantes Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: JCI Insight Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Carcinoma de Pequenas Células do Pulmão / Neoplasias Pulmonares / Células Neoplásicas Circulantes Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: JCI Insight Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França